2020 annual financial data
BioRestorative Therapies 2020 Operating margin
Direct answer
Operating margin was -3,574.12%.
Operating income was -2,752,076 USD and net income was -11,272,687 USD.
Operating cash flow was -1,964,265 USD.
Get free BioRestorative Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 77,000 USD
- Operating income
- -2,752,076 USD
- Net income
- -11,272,687 USD
- Operating cash flow
- -1,964,265 USD